...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: $60m PP Question
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I hope we hear an announcement soon on that Zenith 10 mil shares pre IPO PP,  DM mentioned at the AGM it will be announce soon, so we can't be that far away, 

Hears hoping for the conference next week

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply